Lewisville Building

Frank Vizesi, Ph. D.

Chief Scientific Officer

Frank Vizesi, Ph. D., was appointed Chief Scientific Officer following the merger. Dr. Vizesi previously served as Chief Scientific Officer at SeaSpine, where he joined in September 2015 and previously held the role of Vice President, Orthobiologics Research & Development, and Clinical Affairs. Dr. Vizesi was responsible for research and product development of the orthobiologics portfolio, as well as clinical and preclinical research for all of SeaSpine. He has dedicated his career to the intersection of engineering and biology in spine and orthopaedics and developed and launched market-leading products supported by scientific evidence. Prior to SeaSpine, Dr. Vizesi spent eight years at NuVasive and played a pivotal role in growing its biologics franchise to more than $100 million annual revenue. Dr. Vizesi completed his Ph. D. in Biomedical Engineering, M.E. in Biomedical Engineering, and B.E. in Biomedical Engineering from the University of New South Wales in Sydney, Australia.